Clobetasol propionate emollient 0.05% in the treatment of atopic dermatitis

International Journal of Dermatology
J M MaloneyR Rajagopalan

Abstract

A 4-week, double-blind, randomized clinical trial, comparing the efficacy and safety of clobetasol propionate emollient cream 0.05% and its vehicle, was conducted at four private dermatology clinics in 81 non-hospitalized patients (> or = 12 years old) with moderate-to-severe atopic dermatitis covering 2% or more of their body surface. All patients had at least one lesion 2 cm or more in diameter. Three signs/symptoms of target lesions (erythema, pruritus, and induration/papulation) were scored by investigators on a scale of 0-3 (in 0.5-point increments; 0 = absent, 1 = mild, 2 = moderate, and 3 = severe); the total of the three scores had to be > or = 6 for patients to qualify for study entry. Patients were excluded if they were immunocompromised, pregnant, or nursing; had skin atrophy, telangiectasia or striae in skin areas to be treated; or had received topical treatments for atopic dermatitis within 1 week prestudy, intramuscular triamcinolone within 6 weeks prestudy, or long-term systemic corticosteroid usage within 6 months prestudy. Patients were randomized in a 1:1 ratio to receive either clobetasol propionate emollient 0.05% twice daily (n = 41), or the emollient vehicle twice daily (n = 40), for 4 weeks. A fingertip u...Continue Reading

Citations

Dec 6, 2003·The Journal of Allergy and Clinical Immunology·Mark BoguniewiczThomas Hultsch
Jun 11, 1999·BMJ : British Medical Journal·C Charman
Nov 29, 2011·Dermatologic Clinics·Balvinder Rehal, April W Armstrong
Jul 20, 2011·Seminars in Cutaneous Medicine and Surgery·Judith HongMartin Steinhoff
Jun 6, 2003·The Journal of Investigative Dermatology·Carolyn CharmanHywel Williams
Jan 17, 2007·The British Journal of Dermatology·J CallenB U Wintroub
Apr 5, 2013·Dermatologic Therapy·Kevin B YarbroughEric L Simpson
Apr 14, 2010·Allergy·J Buddenkotte, M Steinhoff
May 2, 2015·Clinical Reviews in Allergy & Immunology·Nicholas K MollanazarGil Yosipovitch
Apr 12, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Laurent BarnesVictoria Rollason
Aug 23, 2016·The British Journal of Dermatology·H NankervisH C Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.